Vir Biotechnology has dosed the first patient in one of three expansion cohorts in its ongoing Phase I clinical trial of ...

Vir Biotechnology (VIR) has advanced its oncology program by dosing the first patient in a Phase 1 expansion cohort for VIR-5500 in metastatic prostate cancer, following encouraging early safety and ...

Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will ...

Add Yahoo as a preferred source to see more of our stories on Google. Lululemon launched its first product using plant-based nylon in April 2023 Biotechnology is the exploitation of biological ...

Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best healthcare penny stocks to buy according to hedge funds. On March 16 ...

Nautilus Biotechnology Inc. (NASDAQ:NAUT) is one of the 8 Best Life Sciences Penny Stocks to Buy. On March 18, Nautilus ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

Looking back on biotechnology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Incyte (NASDAQ:INCY) and its peers. The biotechnology industry is defined by its ...

Jacob Funds, a mutual fund company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded ...

Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer – Updated Phase 1 ...

In a major boost to Nigeria’s capacity to tackle climate change and food insecurity, the JR Biotek Foundation, Mastercard Foundatio, and the University of Cambridge have partnered the Michael Okpara ...

View Lixte Biotechnology Holdings, Inc. LIXT stock quote prices, financial information, real-time forecasts, and company news from CNN.